BlackBarn Capital Partners LP acquired a new stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 135,000 shares of the company’s stock, valued at approximately $3,109,000. Privia Health Group comprises about 1.1% of […]
BlackBarn Capital Partners LP bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 135,000 shares of the company’s stock, valued at approximately $3,109,000. Privia Health Group accounts for […]
Premier Fund Managers Ltd decreased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 41.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,400 shares of the company’s stock after selling 12,564 shares during […]
Equities researchers at Robert W. Baird assumed coverage on shares of Privia Health Group (NASDAQ:PRVA – Get Free Report) in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $23.00 price target on the stock. Robert W. Baird’s target price would suggest a […]
Baird R W upgraded shares of Privia Health Group (NASDAQ:PRVA – Free Report) to a strong-buy rating in a report issued on Thursday morning, Zacks.com reports. A number of other research firms have also recently commented on PRVA. Canaccord Genuity Group lowered their target price on shares of Privia Health Group from $37.00 to $26.00 […]